Chemoinformaics analysis of Mono-O-acetylacoschimperoside P
Molecular Weight | 634.763 | nRot | 6 |
Heavy Atom Molecular Weight | 584.363 | nRig | 33 |
Exact Molecular Weight | 634.335 | nRing | 6 |
Solubility: LogS | -4.354 | nHRing | 2 |
Solubility: LogP | 3.042 | No. of Aliphatic Rings | 6 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
Atoms Count | 95 | No. of Aliphatic Hetero Cycles | 2 |
No. of Heavy Atom | 45 | No. of Aromatic Carbocycles | 0 |
nHetero | 11 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 4 |
No. of Hydrogen atom | 50 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 34 | No. of Saturated Rings | 5 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 11 | No. of Arom Bond | 0 |
nHA | 11 | APOL | 98.9417 |
nHD | 2 | BPOL | 63.1804 |
QED | 0.305 |
Synth | 5.459 |
Natural Product Likeliness | 2.543 |
NR-PPAR-gamma | 0.4 |
Lipinski | Rejected |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.976 |
Pgp-sub | 0.338 |
HIA | 0.945 |
CACO-2 | -5.169 |
MDCK | 0.0000551 |
BBB | 0.428 |
PPB | 0.919302 |
VDSS | 1.301 |
FU | 0.093508 |
CYP1A2-inh | 0.001 |
CYP1A2-sub | 0.104 |
CYP2c19-inh | 0.006 |
CYP2c19-sub | 0.409 |
CYP2c9-inh | 0.047 |
CYP2c9-sub | 0.068 |
CYP2d6-inh | 0.04 |
CYP2d6-sub | 0.18 |
CYP3a4-inh | 0.143 |
CYP3a4-sub | 0.469 |
CL | 4.41 |
T12 | 0.062 |
hERG | 0.065 |
Ames | 0.033 |
ROA | 0.993 |
SkinSen | 0.015 |
Carcinogencity | 0.05 |
EI | 0.005 |
Respiratory | 0.289 |
NR-Aromatase | 0.807 |
Antiviral | Yes |
Prediction | 0.769776 |